Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003144969 | SCV003830643 | uncertain significance | not provided | 2022-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004978776 | SCV005555546 | uncertain significance | Inborn genetic diseases | 2024-08-12 | criteria provided, single submitter | clinical testing | The c.224A>G (p.N75S) alteration is located in exon 3 (coding exon 3) of the CHRNG gene. This alteration results from a A to G substitution at nucleotide position 224, causing the asparagine (N) at amino acid position 75 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |